NUK - logo
E-viri
Recenzirano Odprti dostop
  • HCV-coinfection is related ...
    López-Huertas, Maria Rosa; Palladino, Claudia; Garrido-Arquero, Marta; Esteban-Cartelle, Beatriz; Sánchez-Carrillo, Marta; Martínez-Román, Paula; Martín-Carbonero, Luz; Ryan, Pablo; Domínguez-Domínguez, Lourdes; Santos, Ignacio De Los; Moral, Sara De La Fuente; Benito, José Miguel; Rallón, Norma; Alcamí, José; Resino, Salvador; Fernández-Rodríguez, Amanda; Coiras, Mayte; Briz, Verónica

    Scientific reports, 04/2019, Letnik: 9, Številka: 1
    Journal Article

    In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby likely contributing to increase HIV-1 reservoir that is the major barrier for its eradication. Our objective was to evaluate the influence of HCV coinfection in HIV-1 viral reservoir size in resting (r) CD4+ T-cells (CD25-CD69-HLADR-). Multicenter cross-sectional study of 97 cART-treated HIV-1 patients, including 36 patients with HIV and HCV-chronic co-infection without anti-HCV treatment, 32 HIV patients with HCV spontaneous clearance and 29 HIV-monoinfected patients. rCD4+ T-cells were isolated and total DNA was extracted. HIV viral reservoir was measured by Alu-LTR qPCR. Differences between groups were calculated with a generalized linear model. Overall, 63.9% were men, median age of 41 years and Caucasian. Median CD4+ and CD8+ T-lymphocytes were 725 and 858 cells/mm , respectively. CD4+ T nadir cells was 305 cells/mm . Proviral HIV-1 DNA size was significantly increased in chronic HIV/HCV-coinfected compared to HIV-monoinfected patients (206.21 ± 47.38 vs. 87.34 ± 22.46, respectively; P = 0.009), as well as in spontaneously clarified HCV co-infected patients when compared to HIV-monoinfected individuals (136.20 ± 33.20; P = 0.009). HIV-1/HCV co-infected patients showed a larger HIV-1 reservoir size in comparison to HIV-monoinfected individuals. This increase could lead to a greater complexity in the elimination of HIV-1 reservoir in HIV-1/HCV-coinfected individuals, which should be considered in the current strategies for the elimination of HIV-1 reservoir.